Amarantus has Todos ($550,000+ in July plus gro
Post# of 30028
(Total Views: 482)
Posted On: 08/07/2020 10:57:28 AM
Amarantus has
Todos ($550,000+ in July plus growth worldwide & expanding other tests)
Carie is building something big, so the payoff is looking to be more and more solid.
(With $20 million on the books)
Theralink is now beginning to make moves with its tests and possibly with its lab.
AMBS is a beneficiary of all 3.
Plus it still has Elto Pharma (Eltoprazine)
(Amarantus recently received an independent third-party valuation report which valued the Parkinson's disease levodopa-induced dyskinesia (PD-LID) indication for Eltoprazine in the US and Europe at $316 million...June 2018)
Hempori
Hempori generated over $350,000 from its 2 storefronts in fiscal year 2019.
Hempori has continued to generate revenue as it transitions to online. - June 8th Tweet
"We have signed multiple LOIs regarding product partnerships with leading companies, and international distribution channels, as well as leading doctors for professional sports teams (NFL/NBA) who love the pain cream" - Gerald Tweet
With very little out going costs now.
Things are changing, without a doubt.
Don't see about a penny and a half as a true valuation for much longer.
Todos ($550,000+ in July plus growth worldwide & expanding other tests)
Carie is building something big, so the payoff is looking to be more and more solid.
(With $20 million on the books)
Theralink is now beginning to make moves with its tests and possibly with its lab.
AMBS is a beneficiary of all 3.
Plus it still has Elto Pharma (Eltoprazine)
(Amarantus recently received an independent third-party valuation report which valued the Parkinson's disease levodopa-induced dyskinesia (PD-LID) indication for Eltoprazine in the US and Europe at $316 million...June 2018)
Hempori
Hempori generated over $350,000 from its 2 storefronts in fiscal year 2019.
Hempori has continued to generate revenue as it transitions to online. - June 8th Tweet
"We have signed multiple LOIs regarding product partnerships with leading companies, and international distribution channels, as well as leading doctors for professional sports teams (NFL/NBA) who love the pain cream" - Gerald Tweet
With very little out going costs now.
Things are changing, without a doubt.
Don't see about a penny and a half as a true valuation for much longer.
(1)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼